Home » Analyst Articles – US

Image for FuelCell Energy (NASDAQ:FCEL) Downgraded by Zacks Investment Research to “Sell”

FuelCell Energy (NASDAQ:FCEL) Downgraded by Zacks Investment Research to “Sell”

Zacks Investment Research downgraded shares of FuelCell Energy (NASDAQ:FCEL) from a hold rating to a sell rating in a report released on Tuesday morning, Zacks.com reports. According to Zacks, “FuelCell Energy develops and markets... More of this article »
Image for Adamis Pharmaceuticals (NASDAQ:ADMP) Rating Lowered to Strong Sell at Zacks Investment Research

Adamis Pharmaceuticals (NASDAQ:ADMP) Rating Lowered to Strong Sell at Zacks Investment Research

Zacks Investment Research cut shares of Adamis Pharmaceuticals (NASDAQ:ADMP) from a hold rating to a strong sell rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “Adamis Pharmaceuticals... More of this article »
Image for Cross Country Healthcare (NASDAQ:CCRN) PT Raised to $20.00 at BMO Capital Markets

Cross Country Healthcare (NASDAQ:CCRN) PT Raised to $20.00 at BMO Capital Markets

Cross Country Healthcare (NASDAQ:CCRN) had its price target hoisted by equities research analysts at BMO Capital Markets from $17.00 to $20.00 in a note issued to investors on Monday, The Fly reports. The brokerage presently has an... More of this article »
Image for SoFi Technologies (NASDAQ:SOFI) Now Covered by Analysts at Rosenblatt Securities

SoFi Technologies (NASDAQ:SOFI) Now Covered by Analysts at Rosenblatt Securities

Rosenblatt Securities initiated coverage on shares of SoFi Technologies (NASDAQ:SOFI) in a research note released on Tuesday morning, The Fly reports. The firm issued a buy rating on the stock. Separately, Oppenheimer initiated coverage... More of this article »
Image for Natera (NASDAQ:NTRA) Research Coverage Started at Raymond James

Natera (NASDAQ:NTRA) Research Coverage Started at Raymond James

Raymond James started coverage on shares of Natera (NASDAQ:NTRA) in a report issued on Tuesday, PriceTargets.com reports. The brokerage issued a market perform rating on the medical research company’s stock. Several other equities... More of this article »